Clinical research at UCLH attracts £6.5 million in funding 

18/11/2016 00:00 
The clinical research facility at UCLH has been awarded £6.5 million in funding towards experimental medicine studies, including cancer and dementia.
 
The announcement was made today by the National Institute of Health Research as part of an investment of more than £40 million in groundbreaking clinical research facilities in London.
 
UCLH was one of eight successful CRFs across London to receive NIHR funding for 2017 to 2022 following a competitive bidding process.
 
The further funding of £6.5 million for UCLH represents an 18 per cent increase from the funding awarded in 2012 to progress high quality clinical research, and to safely and efficiently deliver new treatments to patients to improve their outcomes.
 
UCLH hosts two clinical research facilities, one at 170 Tottenham Court Road and one at Queen Square under the name Leonard Wolfson Experimental Neurology Centre (LWENC).
 
Today’s announcement was made after the Parliamentary Under-Secretary of State for Public Health visited the facility at 170 Tottenham Court Road to see for herself the work of a London facility.
 
Nicola Blackwood MP said: “Our national investment in this area so far has led to a variety of breakthroughs, including the first new asthma treatment in a decade, and a promising treatment for peanut allergies in children, to name just two. We know that such ground breaking clinical research simply would not happen without the support of these Clinical Research Facilities. I’m delighted to announce this funding to support the skilled personnel and cutting-edge facilities we need to keep London at the forefront of clinical research.”
 
UCLH’s acting chief executive Neil Griffiths said: “This renewed funding is fantastic news for our patients and will go far to reinforce the areas of research where we are already world leaders. I am delighted that we will be able to continue our work in a range of clinical areas and I would like to congratulate everybody involved.”
 
Director of research Professor Bryan Williams said: “Today's health research is tomorrow's healthcare so I am delighted with the news our CRF has received this uplift in funding. The additional support we will get from the NIHR will enable us to progress even more exciting studies from the laboratory bench to the hospital bedside.”
 
The news was also welcomed by UCLH’s CRF director Vincenzo Libri who said: “It is a very exciting time ahead and we are determined to uphold our promise to expedite the early evaluation of novel treatments for the most challenging, complex and difficult diseases, and make discoveries in the understanding, diagnosis and treatment of diseases, such as cancer, dementia and other neurodegenerative disorders, with the ultimate goal of offering a better future to patients and their families."

 Latest news

 Contact details

Communications unit
2nd floor central
250 Euston Road
London NW1 2PG

Media enquiries

Switchboard: 020 3456 7890
Media enquiries: 020 3447 7542 / 020 3447 9506
Email: uclh.media@nhs.net

Out of hours
The normal working hours for the Communications Unit are Monday to Friday 9am – 5pm. The only media enquiries that will be answered outside of these working hours are urgent enquiries and those relating to major incidents. To access the out-of-hours service call switchboard on 0845 155 5000.

Share this story